NPI: 1235178591 · WINCHESTER, VA 22601 · Urgent Care Clinic/Center · NPI assigned 06/05/2006
Authorized official CHAMBERS, JILL controls 20+ related entities in our dataset. Read more
| Authorized Official | CHAMBERS, JILL (MANAGER INSURANCE CREDENTIALING) |
| Parent Organization | VALLEY REGIONAL ENTERPRISES, INC |
| NPI Enumeration Date | 06/05/2006 |
Other providers sharing the same authorized official: CHAMBERS, JILL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,121 | $624K |
| 2019 | 26,770 | $1.10M |
| 2020 | 19,310 | $891K |
| 2021 | 26,658 | $1.18M |
| 2022 | 51,842 | $1.55M |
| 2023 | 54,261 | $1.65M |
| 2024 | 41,288 | $1.56M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 44,262 | 40,580 | $3.34M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 40,938 | 38,253 | $2.39M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11,098 | 10,662 | $802K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4,936 | 4,711 | $523K |
| 87428 | 15,418 | 14,693 | $516K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 26,013 | 24,412 | $325K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 15,382 | 7,241 | $187K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5,615 | 5,348 | $153K |
| 87430 | 11,031 | 10,481 | $138K | |
| 3074F | 14,040 | 13,089 | $35K | |
| 3078F | 13,019 | 12,169 | $31K | |
| 71046 | Radiologic examination, chest; 2 views | 1,254 | 1,194 | $29K |
| 3079F | 5,147 | 4,850 | $13K | |
| 99215 | Prolong outpt/office vis | 81 | 75 | $9K |
| 3077F | 3,226 | 3,023 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 521 | 487 | $7K |
| 81003 | 3,676 | 3,427 | $6K | |
| 3075F | 2,971 | 2,820 | $6K | |
| 94760 | 7,160 | 6,675 | $5K | |
| 3080F | 2,121 | 2,001 | $5K | |
| 87807 | 373 | 357 | $5K | |
| 80047 | 518 | 482 | $4K | |
| 99000 | 3,303 | 3,174 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 99 | 98 | $4K |
| 73610 | 139 | 133 | $4K | |
| 85027 | 595 | 551 | $3K | |
| 73630 | 128 | 124 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 68 | 64 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 56 | 55 | $3K |
| 93000 | 193 | 187 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 141 | 133 | $2K |
| 36415 | Collection of venous blood by venipuncture | 690 | 644 | $1K |
| 81025 | 123 | 117 | $762.24 | |
| 73110 | 14 | 13 | $486.21 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 13 | 12 | $438.56 |
| 29125 | 12 | 12 | $437.35 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 87 | 87 | $261.07 |
| 81002 | 89 | 82 | $233.44 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 531 | 496 | $90.79 |
| 99051 | 47 | 45 | $41.25 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 90 | 77 | $24.72 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 13 | 13 | $18.10 |
| 36416 | 19 | 16 | $0.00 |